Cardiovascular Systems | CSII

Cardiovascular Systems traded at $14.97 this Friday June 24th, increasing $0.38 or 2.60 percent since the previous trading session. Looking back, over the last four weeks, Cardiovascular Systems gained 8.78 percent. Over the last 12 months, its price fell by 66.00 percent. Looking ahead, we forecast Cardiovascular Systems to be priced at 14.57 by the end of this quarter and at 13.42 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
14.97
Daily Change
2.60%
Yearly
-66.00%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Terumo 4,111.00 154.00 3.89% -7.41%
Abiomed 255.32 6.70 2.69% -18.05%
Abbott 109.45 3.24 3.05% -2.90%
AngioDynamics 19.24 -0.91 -4.52% -31.04%
AtriCure 40.92 1.48 3.75% -48.96%
Baxter International 66.78 1.70 2.61% -18.75%
Becton, Dickinson and Co. 250.92 8.38 3.46% 4.03%
Boston Scientific 38.02 1.08 2.92% -13.79%
Artivion Inc 19.39 0.26 1.36% -33.55%
Cardiovascular Systems 14.97 0.38 2.60% -66.00%
Dexcom 77.67 2.46 3.27% -81.95%
Edwards Lifesciences 96.98 3.36 3.59% -6.36%
Globus Medical 57.85 1.10 1.94% -25.32%
Hologic 70.93 0.38 0.54% 7.65%
Inogen 26.16 -0.27 -1.02% -60.66%
Intuitive Surgical 209.67 5.17 2.53% -76.92%
J&J 182.29 2.63 1.46% 11.01%
Medtronic 90.22 1.55 1.75% -27.78%
Merit Medical Systems 52.94 -0.54 -1.01% -17.86%
NuVasive 50.67 0.48 0.96% -27.50%
Insulet 227.73 8.76 4.00% -18.18%
ResMed 211.50 4.01 1.93% -13.50%
Stryker 204.43 4.37 2.18% -22.27%
Teleflex 258.05 6.56 2.61% -37.40%
Tandem Diabetes Care 61.52 2.79 4.75% -38.08%
Zimmer Biomet Holdings Inc 108.87 2.47 2.32% -34.36%

Indexes Price Day Year
USND 11608 375.43 3.34% -19.17%
US2000 1766 54.06 3.16% -24.36%

Cardiovascular Systems
Cardiovascular Systems, Inc. is a medical technology company, which is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company has developed patented orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), which is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.